Dysport® Before & After

Real People. Real Results.

 

It’s not a facial transformation — far from it. Dysport® treatment temporarily improves the look of your moderate to severe frown lines between the eyebrows in a way that suits your style.

And no one will know — unless you tell them.

 

Check out our gallery below!

 

SCHEDULE APPOINTMENT

IMPORTANT SAFETY INFORMATION

Constanza

Libby

Chuck

Jennifer

Madison

Jerry

DO NOT TAKE

DYSPORT IF YOU:

 

  • Are allergic to Dysport® or any of the ingredients in Dysport®. See the end of the Dysport® Medication Guide for a list of ingredients in Dysport®
  • Are allergic to cow's milk protein
  • Had an allergic reaction to any other botulinum toxin product, such as Myobloc® (rimabotulinumtoxinB), Botox® (onabotulinumtoxinA) or Xeomin® (incobotulinumtoxinA)
  • Have a skin infection at the planned injection site
  •  

DYSPORT MAY NOT

BE RIGHT FOR YOU IF:

 

  • You have had surgical changes to your face
  • You have very weak muscles in the treatment area
  • Your face looks very different from side to side
  • The injection site is inflamed
  • You have droopy eyelids or sagging eyelid folds
  • You have deep facial scars
  • You have thick, oily skin
  • Your wrinkles can't be smoothed by spreading them apart

 

The only way to know for sure if Dysport® is right for you is to speak with your healthcare provider.

 

¶A secondary endpoint based on Kaplan-Meier estimates of cumulative rate of time to onset of response. The median time to onset of response was 3 days in GL-1 (Dysport 55/105 [52%], Placebo 3/53 [6%]) and GL-2 (Dysport 36/71 [51%], Placebo 9/71 [13%]), and 2 days in GL-3 (Dysport 110/200 [55%], Placebo 4/100 [4%]).4-6

 

#GL-1 and GL-3 evaluated subjects for at least 150 days following treatment. Based on investigator assessment, response was maintained for up to 4 months in both GL-1 (Dysport 24/105 [23%], Placebo 2/53 [4%]) and GL-3 (Dysport 58/200 [29%], Placebo 1/100 [1%]).4,5,7

 

References

Molina B, Grangier Y, Mole B, et al. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study. J Eur Acad Dermatol Venereol. 2015;29(7):1382-8. doi:10.1111/djv.12881. Epub 2014 Dec 12.

Data on file. Ipsen World-Wide Marketing Authorisation Status. Fort Worth, TX: Galderma Laboratories, L.P., February 2017.

Medicines and Healthcare products Regulatory Agency (MHRA). Botulinum Toxin Type A Powder For Solution For Injection (Clostridium botulinum toxin type A - Haemagglutinin complex). http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con108644.pdf . Accessed May 11, 2015.

Data on file. MA-Y-97-52120-719 (GL-1) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.

Data on file. MA-Y-97-52120-718 (GL-3) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.

Data on file. MA-Y-97-52120-085 (GL-2) Clinical Study Report. Fort Worth, TX: Galderma Laboratories, L.P., 2007.

Dysport for Injection Package Insert. Fort Worth, TX: Galderma Laboratories, L.P.; September 2017.

 

 

Facts + Stats

  • Clinically demonstrated up to 4 months1-3*
  • In 3 clinical studies of people whose between the brow frown lines were rated "moderate" or "severe" by a specialist before their treatment with Dysport:3
  • 30 days after treatment, a majority of Dysport users† (55%, 52% and 60% in each of the 3 studies vs. 0% of users treated with placebo) and their specialists both thought their frown lines improved by at least 2 grades to a rating of "none" or "mild" at maximum frown
  • 30 days after treatment, the majority of Dysport users (88%, 85% and 86% in each of the 3 studies vs. 4%, 4% and 0%, respectively, of users treated with placebo) had their frown lines rated by a specialist as "none" or "mild" with at least a 1-grade improvement at maximum frown
  • 30 days after treatment, the majority of Dysport users (74%, 79% and 82% in each of the 3 studies vs. 9%, 1% and 2%, respectively, of users treated with placebo) rated their own frown lines as "none" or "mild" with at least a 1-grade improvement at maximum frown
  • Dysport is used in 69 countries around the world4
  • Ask your specialist if prescription Dysport is right for you.

 

Dysport may not be right for you if: you have surgical changes to your face, very weak muscles in the treatment area, your face looks very different from side to side, the injection site is inflamed, you have droopy eyelids or sagging eyelid folds, deep facial scars, thick oily skin, or if your wrinkles can’t be smoothed by spreading them apart.

 

 

 

  • IMPORTANT SAFETY INFORMATION

    Dysport® (abobotulinumtoxinA) is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age.

     

    Important Safety Information

     

    What is the most important information you should know about Dysport? Spread of Toxin Effects: In some cases, the effects of Dysport and all botulinum toxin products may affect areas of the body away from the injection site. Symptoms can happen hours to weeks after injection and may include swallowing and breathing problems, loss of strength and muscle weakness all over the body, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, or loss of bladder control. Swallowing and breathing problems can be life threatening and there have been reports of death. You are at the highest risk if these problems are pre‐existing before injection.

     

    These effects could make it unsafe for you to drive a car, operate machinery, or do other dangerous activities.

     

    Do not have Dysport treatment if you: are allergic to Dysport or any of its ingredients (see the end ofthe Medication Guide for a list of ingredients), are allergic to cow’s milk protein, had an allergic reaction to any other botulinum toxin product, such as Myobloc®, Botox®, or Xeomin®, have a skin infection at the planned injection site, under 18 years of age, or are pregnant or breastfeeding.

     

    The dose of Dysport is not the same as the dose of any other botulinum toxin product and cannot be compared to the dose of any other product you may have used.

     

    Tell your doctor about any swallowing or breathing difficulties and all your muscle or nerve conditions such as amyotrophic lateral sclerosis [ALS or Lou Gehrig’s disease], myasthenia gravis, or Lambert‐Eaton syndrome, which may increase the risk of serious side effects including difficulty swallowing and difficulty breathing. Serious allergic reactions have occurred with the use of Dysport. Dry eye has also been reported.

     

    Tell your doctor about all of your medical conditions, including if you have surgical changes to your face, very weak muscles in the treatment area, any abnormal facial change, injection site inflammation, droopy eyelids or sagging eyelid folds, deep facial scars, thick oily skin, wrinkles that can’t be smoothed by spreading them apart, or if you are pregnant or breastfeeding or planning to become pregnant or breastfeed.

     

    Tell your doctor about all the medicines you take, , including prescription and nonprescription medicines, vitamins and herbal and other natural products. Using Dysport with certain other medicines may cause serious side effects. Do not start any new medicines while taking Dysport without talking to your doctor first.

     

    Especially tell your doctor if you: have received any other botulinum toxin product, such as Myobloc® (rimabotulinumtoxinB), Botox® (onabotulinumtoxinA), or Xeomin® (incobotulinumtoxinA), in the last four months or any in the past (be sure your doctor knows exactly which product you received, have recently received an antibiotic by injection, take muscle relaxants, take an allergy or cold medicine, or take a sleep medicine.

     

    Common Side Effects

    The most common side effects are nose and throat irritation, headache, injection site pain, injection site skin reaction, upper respiratory tract infection, eyelid swelling, eyelid drooping, sinus inflammation, and nausea.

     

    Ask your doctor if Dysport is right for you.

     

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

     

    Please see Dysport Full Prescribing Information including Medication Guide at DysportUSA.com.

     

 

1327 Hemphill Street, Ste. 200A

Fort Worth, TX 76104